SAMANTHA ANDERSON: Open Payments
NPI 1477638625 · NEW PROVIDENCE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 16 payments from 9 companies in 2025. Trend: 2023 $224 · 2024 $219 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $57 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Novo Nordisk Inc | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Exact Sciences Corporation | 1 | $25 |
| PFIZER INC. | 1 | $19 |
| SANOFI PASTEUR INC. | 1 | $18 |
| Amgen Inc. | 1 | $14 |
Products named: MOUNJARO, SHINGRIX, Wegovy, The Cologuard Plus Collection Kit, ELIQUIS, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, GARDASIL 9, CAPVAXIVE.
Industry payments across NJ — which companies pay providers there.
